Verena Korber
Group Leader
Somatic stem cells sustain tissue homeostasis by tightly balancing self-renewal and differentiation into increasingly fate-restricted progenitor and precursor cells. As we age, somatic tissues acquire variation, which can drive the selective expansion of stem and progenitor cell clones. These expanding clones perturb the balance between cell division and differentiation, and can lead to malignancy or tissue failure as we age. I am interested in a quantitative understanding of human differentiation cascades in healthy individuals, during aging and in malignant transformation. To this end, I leverage advanced mathematical modelling, multi-one next generation sequencing and functional validation in vivo. My research focuses specifically on human hematopoiesis and the nervous system and, ultimately, aims to improve screening, disease monitoring and treatment of cancer.
Key publications
-
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy
Journal article
Pixberg C. et al, (2022), ESMO Open, 7, 100637 - 100637
-
Clonal tracing with somatic epimutations reveals dynamics of blood ageing.
Journal article
Scherer M. et al, (2025), Nature, 643, 478 - 487
-
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
Journal article
Jansky S. et al, (2021), Nature Genetics, 53, 683 - 693
-
Inferring growth and genetic evolution of tumors from genome sequences
Journal article
Körber V. and Höfer T., (2019), Current Opinion in Systems Biology, 16, 1 - 9
-
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability.
Journal article
Smirnov P. et al, (2024), Nat Commun, 15
Recent publications
-
Clonal tracing with somatic epimutations reveals dynamics of blood ageing.
Journal article
Scherer M. et al, (2025), Nature, 643, 478 - 487
-
Detecting and quantifying clonal selection in somatic stem cells.
Journal article
Körber V. et al, (2025), Nat Genet, 57, 1718 - 1729
-
Oncogene aberrations drive medulloblastoma progression, not initiation.
Journal article
Okonechnikov K. et al, (2025), Nature, 642, 1062 - 1072
-
Spatio-temporal transcriptomics of chromothriptic SHH-medulloblastoma identifies multiple genetic clones that resist treatment and drive relapse.
Journal article
Kats I. et al, (2024), Nat Commun, 15
-
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instability.
Journal article
Smirnov P. et al, (2024), Nat Commun, 15